Since the aberrant distribution of H3K9me3 was observed widely in AML patients [28], we therefore, hypothesized that decreased expression of Suv39h1 may contribute to a reduction of genomic H3K9me3 occupancy in LSCs. This evidence concerns the gene SUV39H1 and acute myeloid leukemia.